Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,014 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

NCT01455051

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Spain
  • Hospital de la Santa Creu Sant Pau Barcelona, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
  • Institut Catala d'Oncologia L'Hospitalet de Llobregat, Spain
View Trial Details
Completed

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

NCT01463670

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • SUNY Downstate Medical Center Brooklyn, New York, United States
View Trial Details
Completed

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

NCT00450450

Conditions
Bone Marrow Diseases, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, +29 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Childrens Memorial Hospital Chicago, Illinois, United States
View all 21 locations
View Trial Details

Related conditions